Correction to: Consistent effects of noninvasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, shamcontrolled, double-blind PRESTO trial [1] , the authors notified us that the citation within the Table 1 legend was not presented as initially requested. Also, the word "efficacy" was missed from the background section.
The original publication has been corrected. The incorrect and correct table citations as well as background information are presented below.
Originally published citation:
© 2018 Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, Dorlas S, Geppetti P, Ambrosini A, Sarchielli P, Liebler E, Barbanti P, PRESTO Study Group (2018) Non-invasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study [ Opioids should be discouraged for the acute treatment of migraine due to significant safety concerns and lack of documented but remain frequently used in the emergency department setting, which significantly increases healthcare costs
Corrected Background paragraph:
Opioids should be discouraged for the acute treatment of migraine due to significant safety concerns and lack of documented efficacy but remain frequently used in the emergency department setting, which significantly increases healthcare costs
